Landos Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2020 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Landos Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2024.
- Landos Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$8.5M, a 4.02% decline year-over-year.
- Landos Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$20.5M, a 55.3% increase from 2022.
- Landos Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$45.8M, a 69.1% decline from 2021.
- Landos Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$27.1M, a 17.9% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)